Sven Michel

9PUBLICATIONS
29CO-AUTHORS
Characterisation of biological macromoleculesMolecular targetsBiologically active moleculesPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 17, 2024
Characterization of the TLR9-Activating Potential of LNA-Modified Antisense Oligonucleotides.

Irene Riera-Tur, Julia Hinterdobler, André Maaske

|May 31, 2023
Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 Mice.

Benedikt Kaufmann, Marta de Los Reyes Jiménez, Laela M Booshehri

|Sep 04, 2021
CHOP-ASO Ameliorates Glomerular and Tubular Damage on Top of ACE Inhibition in Diabetic Kidney Disease.

Khurrum Shahzad, Sameen Fatima, Moh'd Mohanad Al-Dabet

|Jul 12, 2021
Investigation of the Activity of Antisense Oligonucleotides Targeting Multiple Genes by RNA-Sequencing.

Sven Michel, Richard Klar, Frank Jaschinski

|Dec 14, 2020
Using RNA-seq to Assess Off-Target Effects of Antisense Oligonucleotides in Human Cell Lines.

Sven Michel, Ksenija Schirduan, Yimin Shen

|Nov 26, 2020
Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis.

Minhong Shen, Shanshan Xie, Michelle Rowicki

Pageof 2